December 2 Weight-loss drugs could become unavailable for millions in coming years The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion people globally and is expected to double by 2030.
December 1 New cancer therapy hunts and destroys deadly tumors in major breakthrough study Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer cells, even after the cancer has spread to other organs.
November 28 Type 1 diabetes reversed in landmark study, paving the way for human studies A Stanford study confirmed a complete reversal of type 1 diabetes in mice through a combination of stem cell transplants and immune system therapies.
November 26 On a GLP-1? How to survive holiday meals without derailing your progress GLP-1 weight-loss drugs can make holiday family dinners challenging, as appetite changes affect social eating habits and relationships with food traditions.
November 24 New weight-loss shot shows major fat reduction, but experts urge caution The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond current GLP-1 medications.
November 22 Hearing loss could be reversed with popular erectile dysfunction drug Genetic hearing loss may be reversible, early research suggests. Scientists test arginine and sildenafil treatments for inherited deafness conditions.
November 21 Daily pill slashes 'bad' cholesterol levels by 60% in yearlong trial A new daily pill reduced bad cholesterol by 60% in a groundbreaking study of 303 adults with a genetic condition, offering hope for heart disease prevention.
November 20 Missouri attorney general takes new legal aim at mail-order abortion pills over safety concerns Missouri attorney general sues FDA over generic mifepristone approval, alleging safety concerns and hospital complications from mail-order abortion pills.
November 17 Fast-growing cancer could be slowed by common blood pressure drug, research shows Scientists accidentally discovered how an old blood pressure drug hydralazine could fight aggressive brain cancer by targeting cellular oxygen sensors.
November 15 Popular diabetes drug could block exercise benefits, new study warns New research reveals metformin may reduce exercise benefits for diabetes patients, affecting blood sugar control and fitness gains in unexpected ways.